2018
DOI: 10.1016/j.brainres.2017.10.015
|View full text |Cite
|
Sign up to set email alerts
|

Investigating the efficacy of a combination Aβ-targeted treatment in a mouse model of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 46 publications
1
18
0
Order By: Relevance
“…In patient’s brain, there is an increased level of MI compared to healthy individuals, despite different pathogenesis of the disease, connected with the accumulation of neurotoxin-toxic amyloid A [86,87]. Liu et al [88] evaluated the brains of mice after 6 months of scyllo -inositol supplementation, observing the lower amyloid A content, the greater activity of microglia and the phagocytosis capacity compared to non-treated mice. Scyllo -inositol binds and stabilizes small soluble conformations of Aβ amyloid that are phagocytosed by microglia [88].…”
Section: Cyclitols For Nervous System Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…In patient’s brain, there is an increased level of MI compared to healthy individuals, despite different pathogenesis of the disease, connected with the accumulation of neurotoxin-toxic amyloid A [86,87]. Liu et al [88] evaluated the brains of mice after 6 months of scyllo -inositol supplementation, observing the lower amyloid A content, the greater activity of microglia and the phagocytosis capacity compared to non-treated mice. Scyllo -inositol binds and stabilizes small soluble conformations of Aβ amyloid that are phagocytosed by microglia [88].…”
Section: Cyclitols For Nervous System Diseasesmentioning
confidence: 99%
“…Liu et al [88] evaluated the brains of mice after 6 months of scyllo -inositol supplementation, observing the lower amyloid A content, the greater activity of microglia and the phagocytosis capacity compared to non-treated mice. Scyllo -inositol binds and stabilizes small soluble conformations of Aβ amyloid that are phagocytosed by microglia [88].…”
Section: Cyclitols For Nervous System Diseasesmentioning
confidence: 99%
“…In the meantime, nine constituents were firstly characterized in rat brain (Supporting Information Table S1 marked # ) with the strategy mentioned above. According to the result, the compounds detected in rat brain are mainly small compounds of Poria and Acori Tatarinowii Rhizoma, which possibly attributed to the limited access of larger compounds to the brain due to the blood–brain barrier .…”
Section: Resultsmentioning
confidence: 99%
“…Further, sI prevents tau hyperphosphorylation (Jin and Selkoe, 2015). These potentially beneficial effects have prompted development of sI and close sI analogs as potential treatments for AD/ADRD (Salloway et al, 2011;Morrone et al, 2016;Lee et al, 2017;Liu et al, 2018). A possible mechanism to explain the low sI signal in supraphysiologic-dose AAS users is that its synthetic enzyme, inositol epimerase, which converts myo-inositol to sI, may be inhibited by AAS.…”
Section: Supraphysiologic-dose Aas Exposures Are Associated With Neurmentioning
confidence: 99%